UKHSA (UK) · Jul 7, 2026
Guidance: Rotavirus vaccination programme: information for healthcare practitioners
Information for health professionals on the rotavirus vaccination programme.
Global Health · page 14
UK, EU & international health agencies
DHSC (UK) · Jul 7, 2026
Official Statistics: UK Clinical Research Delivery key performance indicators: data to July 2026
Report bringing together data on the delivery of globally competitive clinical research through the UK Clinical Research Delivery programme.
DHSC (UK) · Jul 7, 2026
Official Statistics: Medicine supply disruption statistics, UK: data to June 2026
Twice-yearly official statistics on medicine supply issue and discontinuation notifications reported to the Department of Health and Social Care by pharmaceutical suppliers.
MHRA (UK) · Jul 7, 2026
Guidance: Clinical trials for medicines: roles and responsibilities
Which professions can act as an investigator, training and experience expectations, provision of medical support and delegation of activities.
MHRA (UK) · Jul 7, 2026
Decision: Doxecitine and Doxribtimine in the treatment of thymidine kinase 2 deficiency (TK2d)
Doxecitine and Doxribtimine in the treatment of paediatric and adult patients with thymidine kinase 2 deficiency (TK2d) with an age of symptom onset on or before 12 years.
ECDC (EU) · Jul 7, 2026
Amidst heatwave across Europe, ECDC launches improved tool for monitoring the risk of infection in coastal waters
ECDC is launching an updated data visualisation that predicts where the risk of being infected by Vibrio bacteria could be greatest.
NHS England · Jul 6, 2026
Around a million parents urged to book new ‘four-in-one’ NHS jab to protect young children against measles
Around a million families are being urged to protect their children against the spread of measles and other potentially deadly childhood illnesses, as part of a new NHS vaccination drive. Children aged from 12-months to 11 years old who have missed one or both doses of the vaccine, will be invited as part of the […]
MHRA (UK) · Jul 6, 2026
Clinical trials for medicines: ending a clinical trial
Guidance on the process for ending a clinical trial.
MHRA (UK) · Jul 6, 2026
Clinical investigations for medical devices
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
UKHSA (UK) · Jul 6, 2026
Research: Diphtheria: cases among asylum seekers in England, 2022 to 2026
Tables showing confirmed toxigenic C. diphtheriae cases among asylum seekers in England between 2022 and 2026.
UKHSA (UK) · Jul 6, 2026
UKHSA updates heat health alerts across England
The existing yellow heat-health alert for the East Midlands, West Midlands, East of England, London, South East and South West will be escalated to amber
ECDC (EU) · Jul 6, 2026
Enjoying the summer safely: health risks to keep in mind
As people across Europe prepare for holidays, outdoor events, and social gatherings, the ECDC encourages everyone to take a few simple precautions to stay healthy during the summer months.
MHRA (UK) · Jul 6, 2026
Guidance: MHRA Innovation Office
The MHRA’s Innovation Office offers access to expert regulatory guidance for developers of innovative medicines and novel manufacturing processes that face regulatory challenges, uncertainties, or gaps in the current regulatory framework
DHSC (UK) · Jul 6, 2026
NHS sets first-ever staff standards to tackle racism and violence
New NHS staff standards will make employers accountable for tackling racism, violence and sexual harassment, with results published in league tables.
MHRA (UK) · Jul 6, 2026
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced Merkel cell skin cancer
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.
DHSC (UK) · Jul 6, 2026
Policy paper: Departmental minute on public dividend capital write-off: 2025 to 2026
DHSC minute on the cancellation and transfer of outstanding public dividend capital following the dissolution of one NHS trust in 2025.
DHSC (UK) · Jul 6, 2026
Guidance: NHS staff standards
The NHS staff standards set national minimum employment requirements to improve staff experience, outlining employer actions and what staff can expect.
NHS England · Jul 4, 2026
NHS accelerates artificial intelligence rollout to cut waiting times and improve care for millions
A major rollout of new artificial intelligence (AI) tools across the NHS is being accelerated to help cut waiting lists and improve care for millions of patients. A new AI triage tool in the NHS App that helps direct patients to the most appropriate NHS service, as well as widespread access to AI notetaking tools […]
MHRA (UK) · Jul 3, 2026
Semaglutide (Wegovy) approved to treat form of liver disease
The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.
DHSC (UK) · Jul 3, 2026
Policy paper: Air Pollution Awareness Coalition (APAC)
The Air Pollution Awareness Coalition (APAC) is a cross-sector coalition to improve public understanding of air pollution and support action to reduce harm.
NHS England · Jul 3, 2026
NHS to overhaul patient communications and end ‘farce’ of invitations arriving after appointment
Patients are to receive at least 3 weeks’ notice from the NHS for all new planned medical appointments, under plans to overhaul patients’ experiences of the health service. NHS Chief Executive, Sir Jim Mackey, today said that trying to get clarity from the NHS had been “like walking through treacle” for far too many families, […]
MHRA (UK) · Jul 3, 2026
Guidance: Best practice in the labelling and packaging of medicines
This guidance explains the legal framework for labelling and packaging as described in UK legislation and gives best practice for producing medicines labelling and packaging.
MHRA (UK) · Jul 3, 2026
Guidance: Submit changes to labels and Patient Information Leaflets as a self-certification
Guidance for submitting changes to labels and Patient Information Leaflets (PILs) as a self-certification.
UKHSA (UK) · Jul 3, 2026
Form: Measles, mumps or rubella (MMR) referral form
MMR diagnostic form (E8): PCR, genotyping and serology tests